Exponent Investment Management
Exponent Investment Management is a leading private equity firm which targets mid-market businesses across Europe. The firm’s distinctive approach is to identify the potential of family or founder owned businesses and corporate carve-outs. Read more :https://ex-ponent.com
The firm’s latest fund, Exponent Private Equity Partners III, closed last month with PS1 billion of commitments from a broad base of investors. Debevoise’s London team advised on the fundraising.
Wealth Management Simplified: Exponent Investment Management’s Approach
In Ireland, Exponent has made more than EUR 1 billion worth of investments over the past decade. These include Michael Burke’s Chanelle Pharma, a veterinary and medical drugmaker; Gerry Barry’s financial services provider Fintrax (now called Planet Payment); and the Irish engineering design company Ethos Engineering. The firm has also funded three add-on acquisitions at Xeinadin Group, and it has taken a significant minority stake in Graham Paul.
The firm has a strong focus on ESG issues and is committed to integrating them throughout the business. This is driven by the firm’s Head of ESG and Responsible Investment, Lizzie Stazicker, whose role is to help portfolio companies improve their ESG performance. This includes driving a culture of ESG thinking within the businesses and using data to enable internal and external benchmarking. To this end, Novata’s ESG reporting platform has been a useful tool for Exponent, which helps facilitate the production of annual ESG reports and share insights with portfolio companies. This, in turn, enables ESG to drive strategic decision-making by the deal teams.